Treatment of dyslipidemia : initial situation , lipids and control target.
Lipidtarget® is an application for health professionals with responsibility for prescription drugs, which aims to facilitate decision-making on the recommended lipid-lowering therapy in different clinical situations.
Lipidtarget® recommendations are aligned with the strategy of "Treat to Target”, which consider Low Density Lipoprotein cholesterol (LDL-C) as the primary goal of treatment, and follows the leading European clinical practice guidelines 1.2, based on scientific evidence available 3. According to the lipid profile given, Lipidtarget® could make recommendations for the control of other objectives as non High Density Lipoprotein cholesterol (non HDL-C) and / or triglicéridos 4.
Lipidtarget® makes recommendations but not requirements because they are a direct responsibility of the health professional who will account for this, the characteristics of the drug prescribed (on label) and clinical profile of the patient being treated. In this sense, Lipidtarget® should never replace the clinical judgment of health professionals.
The authors of Lipidtarget® are not responsible of inappropriate, irresponsible or fraudulent use of any of the recommendations could give.
BIBLIOGRAPHY
Reiner Z, Catapano A, De Backer G, Graham I, Taskinen M, Wiklund O, et al. ESC/EAS guidelines for the management of dyslipideamias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32: 1769-1878.
Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M et al. European Guidelines in cardiovascular disease prevention in clinical practice (version 2012). The Fith Joint Task Force of The European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in clinical Practice. Eur Heart J doi: 10.1093/eurheartj/ehs092
Mahley RW, Bersot TP. Goodman and Gilman's.The Pharmacological Basis of Therapeutics. New York: McGraw Hill; 2005. p. 933–66
Berglund, L.; Brunzell, J.D.; Goldberg, A.C.; Goldberg, I.J.; Sacks, F.; Murad, M.H.; Stalenhoef, A.F. Evaluation and treatment of hypertriglyceridemia: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2012, 97, 2969–2989.